Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration

Abstract Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on day...

Full description

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2022-05, Vol.9 (5), p.ofac157-ofac157
Main Authors: Goyal, Ashish, Churkin, Alex, Barash, Danny, Cotler, Scott J, Shlomai, Amir, Etzion, Ohad, Dahari, Harel
Format: Article
Language:English
Subjects:
Brief Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofac157